Works matching IS 10648542 AND DT 2022 AND VI 31 AND IP 6
Results: 14
Regulatory Considerations for Digitally Driven Trials.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 6, p. 34
- By:
- Publication type:
- Article
Defining Quality Tolerance Limits and Key Risk Indicators for Timely Risk Detection: Series Part 1: Introduction and the relationship between QTL and KRI, with reflections from early adopters on emerging best practices.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 6, p. 28
- By:
- Publication type:
- Article
Walgreens is Reimagining Clinical Trials for Local Execution, Diverse Participation.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 6, p. 26
- By:
- Publication type:
- Article
Pandemic Challenges and Opportunities for Gender Equity in Clinical Research: Industry must act now to minimize the effects of COVID-era disparity on R&D.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 6, p. 22
- By:
- Publication type:
- Article
Clinical Trial Technology: New Kids on the Block are Changing Industry Dynamics: COVID has accelerated to the scene upstart digital efforts to transform patient engagement and data management/integration--but progress remains measured.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 6, p. 18
- By:
- Publication type:
- Article
Redefining Patient-Centricity: Exploring the Next Best in People, Processes and Technology for the Future of Decentralized Clinical Trials: How patient-centric initiatives guide the clinical drug development Sponsored by process towards increased inclusivity and diversity, patient convenience, safety, research relevance, and ease of use
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 6, p. 12
- By:
- Publication type:
- Article
QUANTIFYING PROTOCOL DEVIATION EXPERIENCE BY CLINICAL PHASE.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 6, p. 10
- By:
- Publication type:
- Article
ADMINISTERING COMPLEX COGNITIVE TESTS REMOTELY IN THE COGNITIVELY-IMPAIRED.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 6, p. 9
- By:
- Publication type:
- Article
ASSESSING USE OF DATA INTEGRATION AND AI IN CLINICAL TRIALS TODAY.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 6, p. 8
- By:
- Publication type:
- Article
REPORT ADMONISHES EMA EFFORTS TO REFORM TRIAL TRANSPARENCY.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 6, p. 7
- By:
- Publication type:
- Article
MORE KIDS DATA.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 6, p. 6
- By:
- Publication type:
- Article
NEW GUIDELINES AIM TO ADVANCE PEDIATRIC DRUG DEVELOPMENT.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 6, p. 6
- By:
- Publication type:
- Article
School's Out for Summer, But Learning Continues.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 6, p. 4
- By:
- Publication type:
- Article
EMERGING TECHNOLOGY.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 6, p. 3
- By:
- Publication type:
- Article